Subcellular mRNA Localization Regulates Ribosome Biogenesis in Migrating Cells.


Journal

Developmental cell
ISSN: 1878-1551
Titre abrégé: Dev Cell
Pays: United States
ID NLM: 101120028

Informations de publication

Date de publication:
09 11 2020
Historique:
received: 16 01 2020
revised: 01 09 2020
accepted: 08 10 2020
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 12 3 2021
Statut: ppublish

Résumé

Translation of ribosomal protein-coding mRNAs (RP-mRNAs) constitutes a key step in ribosome biogenesis, but the mechanisms that modulate RP-mRNA translation in coordination with other cellular processes are poorly defined. Here, we show that subcellular localization of RP-mRNAs acts as a key regulator of their translation during cell migration. As cells migrate into their surroundings, RP-mRNAs localize to the actin-rich cell protrusions. This localization is mediated by La-related protein 6 (LARP6), an RNA-binding protein that is enriched in protrusions. Protrusions act as hotspots of translation for RP-mRNAs, enhancing RP synthesis, ribosome biogenesis, and the overall protein synthesis in migratory cells. In human breast carcinomas, epithelial-to-mesenchymal transition (EMT) upregulates LARP6 expression to enhance protein synthesis and support invasive growth. Our findings reveal LARP6-mediated mRNA localization as a key regulator of ribosome biogenesis during cell migration and demonstrate a role for this process in cancer progression downstream of EMT.

Identifiants

pubmed: 33171110
pii: S1534-5807(20)30796-6
doi: 10.1016/j.devcel.2020.10.006
pmc: PMC7660134
pii:
doi:

Substances chimiques

Autoantigens 0
RNA, Messenger 0
Ribonucleoproteins 0
Ribosomal Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-313.e10

Subventions

Organisme : European Research Council
ID : 617837
Pays : International
Organisme : Medical Research Council
ID : MR/P009417/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Nucleic Acids Res. 2018 Jan 4;46(D1):D229-D238
pubmed: 29126224
Anal Chem. 2012 Sep 4;84(17):7469-78
pubmed: 22880955
Wiley Interdiscip Rev RNA. 2017 Jul;8(4):
pubmed: 28120379
Genes Dev. 2014 Feb 15;28(4):357-71
pubmed: 24532714
J Biol Chem. 2015 Jun 26;290(26):15996-6020
pubmed: 25940091
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Nat Protoc. 2015 Oct;10(10):1543-55
pubmed: 26379228
Cancer Res. 2011 Feb 15;71(4):1418-30
pubmed: 21159662
Cell. 2012 Aug 3;150(3):549-62
pubmed: 22863008
J Proteome Res. 2013 Aug 2;12(8):3809-12
pubmed: 23692318
Nature. 2008 May 1;453(7191):115-9
pubmed: 18451862
Sci Rep. 2019 Jan 23;9(1):326
pubmed: 30674965
EMBO J. 2019 Jul 1;38(13):e100278
pubmed: 31268599
Nat Biotechnol. 2014 Mar;32(3):223-6
pubmed: 24727771
Biostat Bioinforma Biomath. 2013 Aug;3(3):71-85
pubmed: 25558171
J Cell Biol. 2010 Apr 5;189(1):11-2
pubmed: 20368615
RNA Biol. 2019 Oct 10;:1-11
pubmed: 31601159
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):413-8
pubmed: 22160674
Genome Res. 2008 Jan;18(1):1-12
pubmed: 18032727
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Nat Rev Cancer. 2018 Jan;18(1):51-63
pubmed: 29192214
Nature. 2012 Feb 22;485(7396):55-61
pubmed: 22367541
Nat Commun. 2017 Oct 12;8(1):896
pubmed: 29026081
Curr Opin Cell Biol. 2017 Apr;45:38-46
pubmed: 28258033
Cell. 2007 Oct 5;131(1):174-87
pubmed: 17923096
Cell Rep. 2012 Feb 23;1(2):179-84
pubmed: 22832165
PLoS One. 2014 May 06;9(5):e96801
pubmed: 24802416
Genome Res. 2020 Jul;30(7):962-973
pubmed: 32703884
Nucleic Acids Res. 2015 Jan;43(1):645-60
pubmed: 25488812
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Biochim Biophys Acta. 2015 Jul;1849(7):812-20
pubmed: 25735853
Genes Dev. 2016 Mar 1;30(5):594-609
pubmed: 26944682
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Proteomics. 2009 Jan;9(1):205-9
pubmed: 19053139
Cell Rep. 2015 Apr 28;11(4):630-44
pubmed: 25892236
Mol Cell. 2017 Jul 6;67(1):55-70.e4
pubmed: 28673543
J Mol Biol. 2010 Jan 15;395(2):309-26
pubmed: 19917293
BMC Bioinformatics. 2012;13 Suppl 16:S12
pubmed: 23176165
Nature. 2019 Apr;568(7751):193-197
pubmed: 30944477
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Curr Opin Genet Dev. 2005 Feb;15(1):87-96
pubmed: 15661538
Nat Commun. 2019 May 8;10(1):2110
pubmed: 31068593
RNA. 2018 Jan;24(1):98-113
pubmed: 29079635
Nucleic Acids Res. 2018 Nov 16;46(20):11002-11013
pubmed: 30169671
Cell Rep. 2019 Dec 10;29(11):3605-3619.e10
pubmed: 31825839
Science. 2017 Sep 22;357(6357):1299-1303
pubmed: 28798045
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Mol Cell. 1998 Oct;2(4):437-45
pubmed: 9809065
Cell. 2016 Jun 30;166(1):181-92
pubmed: 27321671
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Curr Biol. 2007 May 1;17(9):749-60
pubmed: 17446074
Cell. 2012 Aug 17;150(4):710-24
pubmed: 22901804
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15449-54
pubmed: 20713713
Nature. 2019 Apr;568(7751):259-263
pubmed: 30944473
Methods. 2014 Feb;65(3):274-87
pubmed: 24184352
Bio Protoc. 2018 Jan 5;8(1):
pubmed: 29552591
Cell. 2012 Mar 2;148(5):1015-28
pubmed: 22385965
Nature. 2011 May 19;473(7347):337-42
pubmed: 21593866
Nat Commun. 2017 Sep 19;8(1):583
pubmed: 28928394
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Dev Cell. 2015 Nov 9;35(3):344-57
pubmed: 26555054
Elife. 2017 Apr 07;6:
pubmed: 28379136
Elife. 2017 Jun 26;6:
pubmed: 28650797
Nat Rev Cancer. 2003 Mar;3(3):179-92
pubmed: 12612653
Biochem Soc Trans. 2011 Oct;39(5):1161-5
pubmed: 21936782
Nat Struct Mol Biol. 2010 Jul;17(7):909-15
pubmed: 20601959
Cancer Res. 2010 Jul 1;70(13):5207-12
pubmed: 20516122

Auteurs

Maria Dermit (M)

Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Martin Dodel (M)

Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Flora C Y Lee (FCY)

The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.

Muhammad S Azman (MS)

Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Hagen Schwenzer (H)

Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.

J Louise Jones (JL)

Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Sarah P Blagden (SP)

Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.

Jernej Ule (J)

The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.

Faraz K Mardakheh (FK)

Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: f.mardakheh@qmul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH